Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nuclear Medicine | 16 | 2022 | 585 | 3.07 | Why? |
| Myocardial Perfusion Imaging | 7 | 2019 | 218 | 1.44 | Why? |
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 4 | 2019 | 13 | 1.25 | Why? |
| Cardiac Resynchronization Therapy | 3 | 2019 | 191 | 0.98 | Why? |
| Radionuclide Imaging | 2 | 2020 | 184 | 0.91 | Why? |
| Cardiac Imaging Techniques | 3 | 2021 | 357 | 0.90 | Why? |
| Heart Function Tests | 1 | 2018 | 101 | 0.70 | Why? |
| Nuclear Energy | 3 | 2018 | 6 | 0.55 | Why? |
| Cardiology | 8 | 2021 | 2873 | 0.51 | Why? |
| Radiology Department, Hospital | 1 | 2020 | 805 | 0.46 | Why? |
| Ventricular Dysfunction, Left | 2 | 2019 | 993 | 0.45 | Why? |
| Management Audit | 2 | 2017 | 39 | 0.35 | Why? |
| Single Photon Emission Computed Tomography Computed Tomography | 2 | 2019 | 131 | 0.33 | Why? |
| Tomography, Emission-Computed, Single-Photon | 5 | 2020 | 279 | 0.31 | Why? |
| Radiation Exposure | 2 | 2018 | 161 | 0.29 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2018 | 3051 | 0.29 | Why? |
| Latin America | 2 | 2021 | 1721 | 0.27 | Why? |
| International Agencies | 3 | 2021 | 202 | 0.25 | Why? |
| Women's Health | 2 | 2017 | 444 | 0.24 | Why? |
| Practice Guidelines as Topic | 7 | 2021 | 15421 | 0.22 | Why? |
| Bone Diseases | 2 | 2019 | 101 | 0.21 | Why? |
| Heart Septum | 1 | 2019 | 29 | 0.20 | Why? |
| Laboratories | 3 | 2021 | 2858 | 0.19 | Why? |
| Diastole | 1 | 2019 | 168 | 0.19 | Why? |
| Developing Countries | 4 | 2018 | 4283 | 0.19 | Why? |
| Organotechnetium Compounds | 1 | 2017 | 31 | 0.18 | Why? |
| Radiopharmaceuticals | 2 | 2020 | 763 | 0.17 | Why? |
| Sentinel Lymph Node Biopsy | 1 | 2018 | 173 | 0.17 | Why? |
| Poverty | 3 | 2018 | 2302 | 0.17 | Why? |
| Internationality | 2 | 2020 | 3297 | 0.17 | Why? |
| Clinical Audit | 1 | 2018 | 204 | 0.16 | Why? |
| Caribbean Region | 1 | 2018 | 349 | 0.16 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.16 | Why? |
| Early Detection of Cancer | 2 | 2019 | 1956 | 0.16 | Why? |
| Soft Tissue Infections | 1 | 2017 | 116 | 0.16 | Why? |
| Cardiologists | 1 | 2021 | 366 | 0.16 | Why? |
| Radiation Dosage | 2 | 2018 | 585 | 0.15 | Why? |
| Diagnostic Imaging | 3 | 2020 | 1044 | 0.15 | Why? |
| Equipment and Supplies | 1 | 2020 | 440 | 0.15 | Why? |
| Mammography | 1 | 2019 | 410 | 0.14 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.14 | Why? |
| Technetium | 3 | 2018 | 21 | 0.14 | Why? |
| Oncologists | 1 | 2021 | 877 | 0.14 | Why? |
| Heart Diseases | 2 | 2021 | 3503 | 0.13 | Why? |
| Hospital Departments | 1 | 2020 | 831 | 0.13 | Why? |
| Positron-Emission Tomography | 4 | 2020 | 802 | 0.12 | Why? |
| Ventricular Function, Left | 2 | 2019 | 1555 | 0.12 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.12 | Why? |
| Carcinoma, Squamous Cell | 2 | 2018 | 902 | 0.12 | Why? |
| Stroke Volume | 2 | 2019 | 2153 | 0.12 | Why? |
| Coronary Disease | 1 | 2018 | 645 | 0.12 | Why? |
| Mouth Neoplasms | 1 | 2018 | 463 | 0.12 | Why? |
| Colorectal Neoplasms | 2 | 2018 | 1884 | 0.11 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.11 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.11 | Why? |
| Fluorouracil | 1 | 2012 | 169 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.11 | Why? |
| Intersectoral Collaboration | 1 | 2018 | 1065 | 0.11 | Why? |
| Practice Patterns, Physicians' | 2 | 2021 | 4927 | 0.10 | Why? |
| Breast Neoplasms | 2 | 2019 | 3633 | 0.10 | Why? |
| Humans | 37 | 2022 | 930598 | 0.10 | Why? |
| Societies, Medical | 3 | 2021 | 6907 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 896 | 0.09 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Burnout, Professional | 1 | 2021 | 2489 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.07 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.06 | Why? |
| Pandemics | 13 | 2022 | 389249 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1573 | 0.06 | Why? |
| Health Care Surveys | 2 | 2021 | 2942 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.05 | Why? |
| Technetium Tc 99m Sestamibi | 1 | 2019 | 20 | 0.05 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2021 | 144 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.05 | Why? |
| Female | 13 | 2019 | 380317 | 0.05 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2018 | 1458 | 0.04 | Why? |
| Thallium | 1 | 2017 | 6 | 0.04 | Why? |
| Radiation Protection | 1 | 2018 | 78 | 0.04 | Why? |
| Carcinoma, Large Cell | 1 | 2017 | 13 | 0.04 | Why? |
| Perfusion Imaging | 1 | 2019 | 199 | 0.04 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.04 | Why? |
| Risk | 2 | 2021 | 5288 | 0.04 | Why? |
| Male | 10 | 2019 | 367725 | 0.04 | Why? |
| Signal-To-Noise Ratio | 1 | 2018 | 217 | 0.04 | Why? |
| Aged | 9 | 2019 | 215776 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Incidental Findings | 1 | 2020 | 487 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Middle Aged | 9 | 2019 | 270681 | 0.04 | Why? |
| International Cooperation | 2 | 2019 | 3436 | 0.04 | Why? |
| Radiotherapy | 1 | 2020 | 608 | 0.04 | Why? |
| Coronary Stenosis | 1 | 2018 | 273 | 0.03 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.03 | Why? |
| Lymphatic Metastasis | 1 | 2017 | 537 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2019 | 596 | 0.03 | Why? |
| Maternal Health | 1 | 2017 | 331 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Organoplatinum Compounds | 1 | 2012 | 76 | 0.03 | Why? |
| Leucovorin | 1 | 2012 | 70 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| Reproductive Health | 1 | 2017 | 473 | 0.03 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.03 | Why? |
| Neoplasms | 2 | 2019 | 17251 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| Biomarkers, Pharmacological | 1 | 2012 | 150 | 0.03 | Why? |
| Pharmacogenetics | 1 | 2012 | 222 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.02 | Why? |
| Asia | 1 | 2017 | 2399 | 0.02 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Genotyping Techniques | 1 | 2012 | 360 | 0.02 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2012 | 801 | 0.02 | Why? |
| Heart | 1 | 2018 | 1791 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2019 | 88759 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.02 | Why? |
| Medical Oncology | 1 | 2021 | 3826 | 0.02 | Why? |
| Genome-Wide Association Study | 1 | 2012 | 1648 | 0.02 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 1261 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Nervous System Diseases | 1 | 2019 | 4092 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Adult | 4 | 2019 | 244371 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2012 | 3607 | 0.01 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.01 | Why? |